Polycythemia Vera and Essential Thrombocythemia: A Nationwide Population‐Based Study on Treatment Patterns, Vascular Complications and Survival
This study highlights risk factors associated with complications during treatment in a real-world context and reinforces the role of HU and IFN as first-line therapies in PV and ET.
Authors
- Henrik Holmberg (ORCID: https://orcid.org/0000-0001-6206-3099)
- Anders Själander (ORCID: https://orcid.org/0000-0001-9422-1186)
- Björn Andréasson (ORCID: https://orcid.org/0000-0003-1525-1331)
- Maria Liljeholm
- Henrik Renlund (ORCID: https://orcid.org/0000-0002-2141-6086)
- Anneli Enblom Larsson
Institutions
- Uppsala University (SE)
- NU Hospital Group (SE)
- Umeå University (SE)
Publication Details
- Journal
- European Journal Of Haematology
- Published
- 2026-01-13
- DOI
- https://doi.org/10.1111/ejh.70113
- Primary Topic
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Kempe Foundation
- Neuroförbundet